Targeted Medical Pharma Inc logo

TRGM - Targeted Medical Pharma Inc Share Price

$0.012 0.0  0.0%

Last Trade - 08/06/20

Sector
Healthcare
Size
Micro Cap
Market Cap £278k
Enterprise Value £4.43m
Revenue £4.21m
Position in Universe th / 6344
Bullish
Bearish
Unlock TRGM Revenue
Momentum
Relative Strength (%)
1m +87.7%
3m
6m
1yr
Volume Change (%)
10d / 3m
Price vs... (%)
52w High
50d MA
200d MA
Growth & Value
12m Forecast Rolling Industry Market
Valuation (ttm) Industry Market
Margin of Safety
Qualifying GuruScreens
Financial Summary
Year End 31st Dec 2010 2011 2012 2013 2014 2015 2016E 2017E CAGR / Avg
7.62 8.81 7.30 9.56 7.11 5.26 -7.1%
PEG
Profitability
ROA
%
%
Cashflow
Dividends
Balance Sheet
NFA
m
FINANCIAL BRIEF: : For the fiscal year ended 31 December 2015, Targeted Medical Pharma Inc revenues decreased 26% to $5.3M. Net loss decreased 22% to $3M. Revenues reflect Product Revenue decrease of 27% to $4.7M, Service Revenue decrease of 19% to $523K. Lower net loss reflects Research and Development decrease of 92% to $12K (expense), Change in fair value of derivative liabi increase from $11K to $136K (income), Interest expense decrease of 5% to $1.2M (expense).
Health Trend(F-Score)
0 1 2 3 4 5 6 7 8 9
Bankruptcy Score(Z-Score)
Distress
Cautious
Safe
Earnings Manipulation Risk(M-Score)
Other Ratios
Recent History
Latest interim period vs. prior period Industry Market
3yr Compound Annual Growth Rate Industry Market
Graphical History

Revenue

TRGM Revenue Unlock TRGM Revenue

Net Income

TRGM Net Income Unlock TRGM Revenue

Normalised EPS

TRGM Normalised EPS Unlock TRGM Revenue

PE Ratio Range

TRGM PE Ratio Range Unlock TRGM Revenue

Dividend Yield Range

TRGM Dividend Yield Range Unlock TRGM Revenue
Analyst Forecasts
Price Target:
( below Price)
31st Dec 2020
31st Dec 2021
Est. Long Term Growth Rate: Net Profit
()
EPS
()
DPS
()
Net Profit
()
EPS
()
DPS
()
Consensus Estimate
1m Change
3m Change
Analyst Consensus
Strong Sell Sell Hold Buy Strong Buy
EPS 2019 /  2020
TRGM EPS Forecasts Unlock TRGM Revenue
Profile Summary

Targeted Medical Pharma, Inc. (TMP), also doing business as Physician Therapeutics (PTL), is a specialty pharmaceutical company that develops and commercializes amino acid-based medications. The Company develops and distributes a line of amino acid-based medical food products, dietary supplements and generic drugs to physicians, pharmacies and patients throughout the United States and abroad. The Company operates through TMP, Complete Claims Processing Inc. (CCPI) and Amino Nutritionals segments. TMP develops and distributes amino acid-based therapeutic products and distributes pharmaceutical products from other manufacturers. CCPI segment provides point-of-care dispensing solutions, and billing and collections services. Amino Nutritionals segment develops and distributes amino acid-based dietary supplements directly to consumers. Its products and services include Medical Foods, Medical foods and generic pharmaceuticals, and Billing and Collections.

Directors
Last Annual December 31st, 2015
Last Interim December 31st, 2015
Incorporated October 4, 2006
Public Since September 10, 2012
No. of Shareholders: n/a
No. of Employees: 41
Sector Healthcare
Industry Pharmaceuticals
Index
Exchange OTC Markets Group
Shares in Issue 30,185,727
Free Float (0.0%)
Eligible for
ISAs
SIPPs
TRGM Share Price Performance
Share Price
Bid - Ask
Low - High
Spread
Day's Change
Avg Volume
Open - Close
Range (12m)
Beta
Latest News for TRGM
Upcoming Events for TRGM
Frequently Asked Questions for Targeted Medical Pharma Inc
What is the Targeted Medical Pharma Inc share price?

As of 08/06/20, shares in Targeted Medical Pharma Inc are trading at $0.012, giving the company a market capitalisation of £278k. This share price information is delayed by 15 minutes.

How has the Targeted Medical Pharma Inc share price performed this year?

Shares in Targeted Medical Pharma Inc are currently trading at $0.012 and the price has moved by 91.67% over the past 365 days. In terms of relative price strength - which takes into account the overall market trend - the Targeted Medical Pharma Inc price has moved by 92.23% over the past year.

What are the analyst and broker recommendations for Targeted Medical Pharma Inc?

Of the analysts with advisory recommendations for Targeted Medical Pharma Inc, there are there are currently "buy" , "hold" and "sell" recommendations. The overall consensus recommendation for Targeted Medical Pharma Inc is Not available. You can view the full broker recommendation list by unlocking its StockReport.

When will Targeted Medical Pharma Inc next release its financial results?

Targeted Medical Pharma Inc is scheduled to issue upcoming financial results on the following dates:

Interim results are scheduled for: 2016-12-31
What is the Targeted Medical Pharma Inc dividend yield?

Targeted Medical Pharma Inc does not currently pay a dividend.

Does Targeted Medical Pharma Inc pay a dividend?

Targeted Medical Pharma Inc does not currently pay a dividend.

When does Targeted Medical Pharma Inc next pay dividends?

Targeted Medical Pharma Inc does not currently pay a dividend.

How do I buy Targeted Medical Pharma Inc shares?

To buy shares in Targeted Medical Pharma Inc you'll need a share-dealing account with an online or offline stock broker. Once you have opened your account and transferred funds into it, you'll be able to search and select shares to buy and sell. You can use Stockopedia’s share research software to help you find the the kinds of shares that suit your investment strategy and objectives.

What is the market cap of Targeted Medical Pharma Inc?

Shares in Targeted Medical Pharma Inc are currently trading at $0.012, giving the company a market capitalisation of £278k.

Where are Targeted Medical Pharma Inc shares listed? Where are Targeted Medical Pharma Inc shares listed?

Here are the trading details for Targeted Medical Pharma Inc:

Country of listing: United States
Exchange: OTC
Ticker Symbol: TRGM
What kind of share is Targeted Medical Pharma Inc?

We were not able to load our ranking data for Targeted Medical Pharma Inc

Is there a Targeted Medical Pharma Inc share price forecast 2020?

We were not able to load any forecast data for Targeted Medical Pharma Inc.

How can I tell whether the Targeted Medical Pharma Inc share price will go up?

An important predictor of whether a stock price will go up is its track record of momentum. Price trends tend to persist, so it's worth looking at them when it comes to a share like Targeted Medical Pharma Inc. Over the past six months, the relative strength of its shares against the market has been 0.105k%. At the current price of $0.012, shares in Targeted Medical Pharma Inc are trading at % against their 200 day moving average. You can read more about the power of momentum in assessing share price movements on Stockopedia.

What is the Targeted Medical Pharma Inc PE Ratio?

We were not able to find PE ratio data for Targeted Medical Pharma Inc.

Who are the key directors of Targeted Medical Pharma Inc?

Targeted Medical Pharma Inc's management team is headed by:

Kim Giffoni - EVP
Marcus Charuvastra - CEO
Kerry Weems - NEC
Thomas Wenkart - IND
Douglas Gintz - CTO
Maurice DeWald - IND
Who are the major shareholders of Targeted Medical Pharma Inc?

Here are the top five shareholders of Targeted Medical Pharma Inc based on the size of their shareholding:

Similar to TRGM
© Stockopedia 2020, Refinitiv, Share Data Services.
This site cannot substitute for professional investment advice or independent factual verification. To use it, you must accept our Terms of Use, Privacy and Disclaimer policies.